These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 16580581

  • 1. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R, Bianchi S, Batini V, Guzzo D, Campese VM.
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [Abstract] [Full Text] [Related]

  • 2. Microcirculatory damage of common carotid artery wall in obese and non obese subjects.
    Ciccone M, Maiorano A, De Pergola G, Minenna A, Giorgino R, Rizzon P.
    Clin Hemorheol Microcirc; 1999 Apr; 21(3-4):365-74. PubMed ID: 10711772
    [Abstract] [Full Text] [Related]

  • 3. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 4. Increased carotid intima-media thickness and associations with cardiovascular risk factors in obese and overweight children and adolescents.
    Schiel R, Beltschikow W, Radón S, Kramer G, Perenthaler T, Stein G.
    Eur J Med Res; 2007 Oct 30; 12(10):503-8. PubMed ID: 18024257
    [Abstract] [Full Text] [Related]

  • 5. Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension.
    Bianchi S, Bigazzi R, Nenci R, Campese VM.
    J Nephrol; 1997 Oct 30; 10(6):325-33. PubMed ID: 9442446
    [Abstract] [Full Text] [Related]

  • 6. Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.
    Os I, Nordby G.
    J Cardiovasc Pharmacol; 1992 Oct 30; 20 Suppl 8():S15-21. PubMed ID: 1283764
    [Abstract] [Full Text] [Related]

  • 7. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure.
    Hoffmann IS, Jimenez E, Cubeddu LX.
    J Hum Hypertens; 2001 Jun 30; 15(6):407-12. PubMed ID: 11439316
    [Abstract] [Full Text] [Related]

  • 8. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A, Jarabo-Bueno MM, López-Ruiz A, Solá-Izquierdo E, Morillas-Ariño C, Martínez-Triguero ML.
    Int J Obes (Lond); 2007 Jun 30; 31(6):927-32. PubMed ID: 17264851
    [Abstract] [Full Text] [Related]

  • 9. The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors.
    Quijada Z, Paoli M, Zerpa Y, Camacho N, Cichetti R, Villarroel V, Arata-Bellabarba G, Lanes R.
    Pediatr Diabetes; 2008 Oct 30; 9(5):464-71. PubMed ID: 18507788
    [Abstract] [Full Text] [Related]

  • 10. Vascular risk factors, endothelial function, and carotid thickness in patients with migraine: relationship to atherosclerosis.
    Hamed SA, Hamed EA, Ezz Eldin AM, Mahmoud NM.
    J Stroke Cerebrovasc Dis; 2010 Mar 30; 19(2):92-103. PubMed ID: 20189084
    [Abstract] [Full Text] [Related]

  • 11. Predictors of body mass index and associations with cardiovascular risk factors in Australian children: a prospective cohort study.
    Burke V, Beilin LJ, Simmer K, Oddy WH, Blake KV, Doherty D, Kendall GE, Newnham JP, Landau LI, Stanley FJ.
    Int J Obes (Lond); 2005 Jan 30; 29(1):15-23. PubMed ID: 15314630
    [Abstract] [Full Text] [Related]

  • 12. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol.
    Clifton PM, Bastiaans K, Keogh JB.
    Nutr Metab Cardiovasc Dis; 2009 Oct 30; 19(8):548-54. PubMed ID: 19179060
    [Abstract] [Full Text] [Related]

  • 13. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 Oct 30; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 14. Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects.
    Cubeddu LX, Alfieri AB, Hoffmann IS.
    Am J Hypertens; 2008 Jan 30; 21(1):105-10. PubMed ID: 18091752
    [Abstract] [Full Text] [Related]

  • 15. Cardiorenal risk prevalence in sickle cell hemoglobinopathy.
    Abo-Zenah H, Moharram M, El Nahas AM.
    Nephron Clin Pract; 2009 Jan 30; 112(2):c98-c106. PubMed ID: 19390209
    [Abstract] [Full Text] [Related]

  • 16. Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals.
    Rodrigues SL, Angelo LC, Pereira AC, Krieger JE, Mill JG.
    Int J Cardiol; 2009 Jul 10; 135(3):323-30. PubMed ID: 18929416
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF, Mora C, Muros M, Jarque A, Herrera H, García J.
    J Hypertens; 2008 Nov 10; 26(11):2168-75. PubMed ID: 18854757
    [Abstract] [Full Text] [Related]

  • 19. Impact of obesity in intima media thickness of carotid arteries.
    Kotsis VT, Stabouli SV, Papamichael CM, Zakopoulos NA.
    Obesity (Silver Spring); 2006 Oct 10; 14(10):1708-15. PubMed ID: 17062799
    [Abstract] [Full Text] [Related]

  • 20. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors.
    De Pergola G, Pannacciulli N, Coviello M, Scarangella A, Di Roma P, Caringella M, Venneri MT, Quaranta M, Giorgino R.
    Nutr Metab Cardiovasc Dis; 2008 Mar 10; 18(3):227-32. PubMed ID: 17400434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.